Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights
Sponsored by Johnson & Johnson MedTech – Heart Recovery
Shock
Other coronary interventions
Symposium
Johnson & Johnson MedTech
Room 241
Anchorperson: Alaide Chieffo
Discussants: Mirvat Alasnag, Vasileios Panoulas, Giuseppe Tarantini
Watch this session if you want
- To learn the latest data on Impella in cardiogenic shock
- To learn on how to improve survival of cardiogenic shock patients
- To see latest data and EAPCI consensus on high-risk PCI in patients unsuitable for surgery
Welcome and session objectives
Alaide Chieffo
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction (pPCI)
Mirvat Alasnag
Breaking down cardiogenic shock: an analytical reflection on the DanGer-SHOCK and ECLS-SHOCK trials
Giuseppe Tarantini
One year post DanGer-Shock – Trial insights and subset analysis
Vasileios Panoulas
Session evaluation and key learnings
Alaide Chieffo
